Physician

Robert F Armstrong, MD

According to 2025 Medicare claims, Robert Armstrong, MD (NPI: 1518945617) practices neurology in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is ASHEVILLE NEUROLOGY SPECIALISTS, PA (NPI: 1588614168; TIN: 200912649) and primary practice location at 28806-0366. Armstrong is affiliated with the Mission Health Partners, LLC (ACO ID: A2591) and AdvantagePoint Health Alliance - Western North Carolina, LLC (ACO ID: A5039), participating under the MSSP model.

Armstrong's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 749 traditional Medicare patients, billed 78,083 HCPCS/CPT codes, and received $1,777,294 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,570 prescription claims across 600 beneficiaries totaling $5,057,063 in drug costs, led by Vyvgart (Efgartigimod Alfa-Fcab). 2016 DME data shows 39 claims. Open Payments data shows 148 records totaling $468,031. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $361,155 to $1,777,294. Similarly, Part D prescription costs have risen steadily, from $2,457,985 to $5,057,063. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $7,930 to $21,478.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$889K$1.8M2015 Medicare payment: $361,155 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $285,344 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $267,648 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $351,379 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $354,900 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $464,062 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $476,127 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $930,997 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,177,914 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,777,294 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,04018,570$361,155
20161,09012,234$285,344
20171,11311,085$267,648
20181,06413,100$351,379
20191,09112,607$354,900
20201,07518,031$464,062
20211,10315,992$476,127
20221,05920,269$930,997
202392353,582$1,177,914
202474978,083$1,777,294

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.5M$5.1M2015 Drug cost: $2,457,985 (USD; Tot_Drug_Cst)2016 Drug cost: $2,764,500 (USD; Tot_Drug_Cst)2017 Drug cost: $2,964,531 (USD; Tot_Drug_Cst)2018 Drug cost: $2,834,738 (USD; Tot_Drug_Cst)2019 Drug cost: $2,981,478 (USD; Tot_Drug_Cst)2020 Drug cost: $3,283,788 (USD; Tot_Drug_Cst)2021 Drug cost: $3,440,915 (USD; Tot_Drug_Cst)2022 Drug cost: $3,802,669 (USD; Tot_Drug_Cst)2023 Drug cost: $4,724,938 (USD; Tot_Drug_Cst)2024 Drug cost: $5,057,063 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20157246,445$2,457,985
20167646,989$2,764,500
20177286,791$2,964,531
20186866,159$2,834,738
20197305,983$2,981,478
20206876,045$3,283,788
20216715,587$3,440,915
20226094,660$3,802,669
20235884,033$4,724,938
20246003,570$5,057,063

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.6K$3.2K2015 Medicare payment: $3,169 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $3,108 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R13$3,169
2016N/R39$3,108
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more264379$79
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more162187$58
99309Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes98262$55
99308Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more8398$25
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's290377$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VyvgartEfgartigimod Alfa-Fcab19567$1,321,482
SolirisEculizumab12336$626,208
EpidiolexCannabidiol (Cbd)832,712$399,191
GilenyaFingolimod Hcl12360$125,532
HizentraImmun Glob G(Igg)/Pro/Iga 0-5018504$118,511

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.138$3,195MDD US Operations, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.10$464,836Novartis Pharmaceuticals Corporation
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Robert F. Armstrong, MD?

Tedicare shows public-source Medicare data for Robert F. Armstrong, MD (NPI 1518945617), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert F. Armstrong, MD have ACO affiliation data?

Robert F. Armstrong, MD is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591) and AdvantagePoint Health Alliance - Western North Carolina, LLC (MSSP, ACO ID A5039).

What billing organization is linked to Robert F. Armstrong, MD?

Robert F. Armstrong, MD is linked to ASHEVILLE NEUROLOGY SPECIALISTS, PA (billing NPI 1588614168) in the available physician profile data.

Does Robert F. Armstrong, MD have Open Payments data?

Robert F. Armstrong, MD has 148 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.